MD Anderson News Release 06/27/14
Scientists have long believed that obese women who developed estrogen-positive (ER+) breast cancer were at higher risk for death from the illness than lean women with the same diagnosis. Close to 75 percent of all breast cancers are estrogen receptor-positive and will proliferate in response to the female hormone estrogen.
A new study comparing obese mice with breast cancer and biological...
MD Anderson News Release 06/26/14
The University of Texas System named MD Anderson scientist Lynda Chin, M.D., as a recipient of the...
Diane Barber, Ph.D., of The University of Texas MD Anderson Cancer Center, is the recipient of the 2014 Ethel Fleming Arceneaux Outstanding...
How will any one patient fare with their cancer treatment program? It’s a question with no easy answer.
By mining the readily available data from The Cancer Genome Atlas (TCGA), scientists hope to answer this question by examining both molecular information and traditional clinical variables such as age or tumor stage. Their goal is nothing short of translating biological data into clinical use.
The Cancer Genome Atlas...
MD Anderson News Release 06/20/14
The first Tang Prize for Biopharmaceutical Science has been awarded to Jim Allison, Ph.D., chair...
MD Anderson News Release 06/20/14
Li Ma, Ph.D., assistant professor of Experimental Radiation Oncology at The University of Texas MD...
The following is a statement from The University of Texas MD Anderson Cancer Center in response to several inquiries about...
When cancer-promoting Kras is blocked, Yap1 steps up to fuel tumor recurrence
MD Anderson News Release 06/19/14
Pancreatic...
Older technique associated with higher rate of complications, specifically lymphedema
MD Anderson News Release 06/18/14
African...
MD Anderson study also highlights surgeon’s influence on patient care, decision-making
MD Anderson News Release 06/09/14
Needle...